Ivermectin to reduce malaria transmission II. Considerations regarding clinical development pathway

The development of ivermectin as a complementary vector control tool will require good quality evidence. This paper reviews the different eco-epidemiological contexts in which mass drug administration with ivermectin could be useful. Potential scenarios and pharmacological strategies are compared in...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaccour, Carlos, Rabinovich, N. Regina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402168/
https://www.ncbi.nlm.nih.gov/pubmed/28434405
http://dx.doi.org/10.1186/s12936-017-1802-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402168/
https://www.ncbi.nlm.nih.gov/pubmed/28434405
http://dx.doi.org/10.1186/s12936-017-1802-3

Ejemplares similares